Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RAUL A PENA

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1164456943
CMS profile
7300
Location
MCALLEN, TX

General Payments · PY2018–2024

$7,296.73

  • Reported across 139 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$564.02

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $564.02 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Bausch & Lomb Americas Inc. $205.83 2
Alcon Laboratories Inc $157.37 3
Sight Sciences, Inc. $62.89 3
ABBVIE INC. $56.15 2
Tarsus Pharmaceuticals, Inc. $41.24 2
RxSight Inc $40.54 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $943.99 19
PY2019 $1,139.68 25
PY2020 $675.33 17
PY2021 $1,074.66 21
PY2022 $1,584.61 26
PY2023 $1,314.44 17
PY2024 $564.02 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.63 05/09/2024 Food and Beverage Undisputed 01/23/2026 1105230006 CMS
ABBVIE INC. $33.52 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105230009 CMS
Alcon Vision LLC $102.37 05/06/2024 Food and Beverage Undisputed 01/23/2026 1110567757 CMS
Alcon Vision LLC $24.18 05/07/2024 Food and Beverage Undisputed 01/23/2026 1110567753 CMS
Alcon Vision LLC $30.82 06/21/2024 Food and Beverage Undisputed 01/23/2026 1110567755 CMS
Bausch & Lomb Americas Inc. $121.59 03/29/2024 Food and Beverage Undisputed 01/23/2026 1140431158 CMS
Bausch & Lomb Americas Inc. $84.24 10/14/2024 Food and Beverage Undisputed 01/23/2026 1140431160 CMS
RxSight Inc $23.99 02/07/2024 Food and Beverage Undisputed 01/23/2026 1144224969 CMS
RxSight Inc $16.55 12/06/2024 Food and Beverage Undisputed 01/23/2026 1144224977 CMS
Sight Sciences, Inc. $16.89 05/06/2024 Food and Beverage Undisputed 01/23/2026 1151929997 CMS
Sight Sciences, Inc. $22.63 07/19/2024 Food and Beverage Undisputed 01/23/2026 1151929999 CMS
Sight Sciences, Inc. $23.37 11/21/2024 Food and Beverage Undisputed 01/23/2026 1151930001 CMS
Tarsus Pharmaceuticals, Inc. $24.65 11/06/2024 Food and Beverage Undisputed 01/23/2026 1139123984 CMS
Tarsus Pharmaceuticals, Inc. $16.59 11/07/2024 Food and Beverage Undisputed 01/23/2026 1139123986 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.